Monday, November 08, 2021 12:21:00 PM
We were driving home yesterday afternoon listening to I think NPR.
It cost health insurance companies about $80,000 for every unvaccinated covid hospitalized patient without ventilators.
We all will be getting letters soon.
I assume vax or get dropped date DEC 31, 2021
The Cost Of Being Unvaccinated Just Went Up - Forbeshttps://www.forbes.com › sites › roberthart › 2021/08/19
Aug 19, 2021 — The Cost Of Being Unvaccinated Just Went Up — Most Insurers Are Passing Costs Back To Patients As Covid Hospitalizations Soar.
Unvaccinated Covid Patients Cost US Health System Billionshttps://www.forbes.com › sites › roberthart › 2021/08/23
Aug 23, 2021 — These preventable hospitalizations cost the U.S. healthcare system around $2.3 billion, the Kaiser report said, based on an average Covid-19 ...
Health Insurance Update: COVID could cost you your life, or ...https://bainbridgechamber.com › News
Sep 7, 2021 — Estimates of the cost of a COVID hospital stay vary, but average being in the $20,000 to $80,000 price range, with ICU cases easily topping ...
It cost health insurance companies about $80,000 for every unvaccinated covid hospitalized patient without ventilators.
We all will be getting letters soon.
I assume vax or get dropped date DEC 31, 2021
The Cost Of Being Unvaccinated Just Went Up - Forbeshttps://www.forbes.com › sites › roberthart › 2021/08/19
Aug 19, 2021 — The Cost Of Being Unvaccinated Just Went Up — Most Insurers Are Passing Costs Back To Patients As Covid Hospitalizations Soar.
Unvaccinated Covid Patients Cost US Health System Billionshttps://www.forbes.com › sites › roberthart › 2021/08/23
Aug 23, 2021 — These preventable hospitalizations cost the U.S. healthcare system around $2.3 billion, the Kaiser report said, based on an average Covid-19 ...
Health Insurance Update: COVID could cost you your life, or ...https://bainbridgechamber.com › News
Sep 7, 2021 — Estimates of the cost of a COVID hospital stay vary, but average being in the $20,000 to $80,000 price range, with ICU cases easily topping ...
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
